Company Data
Raphael Pharmaceutical Inc Com (New)
Ticker
RAPH
Current Price
$1.65
Market Cap
$30.9M
Price Target
Refer to Report
52wk Range
$0.6 - $1.65
Overview
Raphael Pharmaceutical Inc., a pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabidiol and oil. It develops product candidate for the treatment of rheumatoid arthritis, oncology indications, and hyper inflammatory syndrome inflammation related to COVID-19. Raphael Pharmaceutical Inc. is headquartered in Tel Aviv-Yafo, Israel.